Beacon Biomedical Inc. Appoints Industry Veteran To Lead Cancer Screening Technology Commercialization

Posted on Wed/27/AprilWed/27/April by AZBio

Phoenix, AZ – April 25, 2016: Beacon Biomedical, Inc., a privately held company focused on developing highly accurate laboratory and point-of-care blood tests for early colorectal cancer screening, announced that it has appointed Dave English as Director of Business Development.Continue reading→

TGen tracks the origins and spread of potentially deadly Valley Fever

Posted on Tue/26/AprilTue/26/April by AZBio

Latest in genomic technologies could track sources of future infectious outbreaksContinue reading→

Sharing Clinical Trial Data for Multiple Sclerosis

Posted on Tue/26/AprilTue/26/April by AZBio

Standardized and Pooled Data Available for Secondary ResearchContinue reading→

AZBio Watch List for April 25 2016

Posted on Mon/25/AprilMon/25/April by AZBio

Learn more about the bills AZBio is tracking at the Arizona Legislature
Continue reading→

New TB Clinical Trial Data-Sharing Platform Available for Reseachers

Posted on Mon/18/AprilMon/18/April by AZBio

The Critical Path Institute (C-Path), the Special Programme for Research and Training in Tropical Diseases (TDR), TB Alliance, and St. George’s, University of London, are pleased to announce the launch of the TB-Platform for Aggregation of Clinical TB Studies (TB-PACTS).Continue reading→

AZBio Bill List for April 18 2016

Posted on Sun/17/AprilSun/17/April by AZBio

AZBio Members are encouraged to share thoughts on these bills and others with the Government Affairs Committee. Email AZBioContinue reading→

TGen researchers go to bat for cancer patients in two innovative clinical trials for pancreatic cancer patients

Posted on Fri/15/AprilFri/15/April by AZBio

Mattress Firm-funded trials seek to shrink tumors in advanced casesContinue reading→

Stand Up To Cancer Launches “Catalyst,” a New Research Program Supported by Industry

Posted on Wed/13/AprilSat/16/April by AZBio

Collaborative program sponsored by Merck, Bristol-Myers Squibb and Genentech will fund efforts to drive cancer research

Continue reading→

La Pitié Hospital, Paris, has implanted more SynCardia Total Artificial Hearts than any other medical center in the world.

Posted on Wed/13/AprilWed/13/April by AZBio

World’s Leading Artificial Heart Center, La Pitié Hospital, Paris, Celebrates 30 Years and 249 Implants of the SynCardia Total Artificial HeartContinue reading→